MeSH Browser

MeSH Heading: Heparin, Low-Molecular-Weight
Tree Number(s): D09.698.373.400.300
Unique ID: D006495
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D006495
Annotation: /antag = probably HEPARIN ANTAGONISTS
Scope Note: Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Entry Version: HEPARIN LMW
Entry Term(s): LMWH; Low Molecular Weight Heparin; Low-Molecular-Weight Heparin
Pharm Action: Anticoagulants
Fibrinolytic Agents
Registry Numbers: 0
NLM Classification #: QV 193
Previous Indexing: Heparin (1966-1987)
Public MeSH Note: 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93
Online Note: use HEPARIN, LOW-MOLECULAR-WEIGHT to search ENOXAPARIN 1990-93 & HEPARIN, LOW MOLECULAR WEIGHT 1988-93
History Note: 94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93
Date Established: 1988/01/01
Date of Entry: 1987/03/25
Revision Date: 2004/07/07

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Carbohydrates [D09]
- Polysaccharides [D09.698]
  - Glycosaminoglycans [D09.698.373]
    - Heparin [D09.698.373.400]
      - Heparin, Low-Molecular-Weight [D09.698.373.400.300]
        
        Dalteparin [D09.698.373.400.300.150]
        
        Enoxaparin [D09.698.373.400.300.200]
        
        Nadroparin [D09.698.373.400.300.600]
        
        Tinzaparin [D09.698.373.400.300.800]
      - Heparinoids [D09.698.373.400.320]

Heparin, Low-Molecular-Weight Preferred

Concept UI: M0010191
Registry Numbers: 0
Scope Note: Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Terms: Heparin, Low-Molecular-Weight Preferred Term
Term UI T019589
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1988); Low Molecular Weight Heparin
Term UI T019587
Date03/01/1993
LexicalTag NON
ThesaurusID NLM (1994); Low-Molecular-Weight Heparin
Term UI T019588
Date03/25/1987
LexicalTag NON
ThesaurusID UNK (19XX); LMWH
Term UI T019590
Date12/09/1992
LexicalTag ABB
ThesaurusID NLM (1994)

Heparin, Low-Molecular-Weight MeSH Descriptor Data 2024